Steven McGinn; David Bauer; Thomas Brefort; Liqin Dong; Afaf El-Sagheer; Abdou Elsharawy; Geraint Evans; Elin Falk-Sörqvist; Michael Forster; Simon Fredriksson; Peter Freeman; Camilla Freitag; Joachim Fritzsche; Spencer Gibson; Mats Gullberg; Marta Gut; Simon Heath; Isabelle Heath-Brun; Andrew J. Heron; Johannes Hohlbein; Rongqin Ke; Owen Lancaster; Ludovic Le Reste; Giovanni Maglia; Rodolphe Marie; Florence Mauger; Florian Mertes; Marco Mignardi; Lotte Moens; Jelle Oostmeijer; Ruud Out; Jonas Nyvold Pedersen; Fredrik Persson; Vincent Picaud; Dvir Rotem; Nadine Schracke; Jennifer Sengenes; Peer F. Stähler; Björn Stade; David Stoddart; Xia Teng; Colin D. Veal; Nathalie Zahra; Hagan Bayley; Markus Beier; Tom Brown; Cees Dekker; Björn Ekström; Henrik Flyvbjerg; Andre Franke; Simone Guenther; Achillefs N. Kapanidis; Jane Kaye; Anders Kristensen; Hans Lehrach; Jonathan Mangion; Sascha Sauer; Emile Schyns; Jörg Tost; Joop M. L. M. van Helvoort; Pieter J. van der Zaag; Jonas O. Tegenfeldt; Anthony J. Brookes; Kalim Mir; Mats Nilsson; James P. Willcocks; Ivo G. Gut
N. Biotechnol., 2016, 33(3), 311-30
https://doi.org/10.1016/j.nbt.2015.10.003

Abstract

The REvolutionary Approaches and Devices for Nucleic Acid analysis (READNA) project received funding from the European Commission for 41/2 years. The objectives of the project revolved around technological developments in nucleic acid analysis. The project partners have discovered, created and developed a huge body of insights into nucleic acid analysis, ranging from improvements and implementation of current technologies to the most promising sequencing technologies that constitute a 3(rd) and 4(th) generation of sequencing methods with nanopores and in situ sequencing, respectively